"Biomedical Engineering Letters (BMEL)" is an academic journal dedicated to the field of biomedical engineering, committed to rapidly disseminating innovative experimental sciences, technological advancements, and emerging clinical applications within this domain. The journal emphasizes the publication of original biomedical engineering research, including the creation of new technologies, in-depth theoretical analysis, and the evaluation and verification of techniques.

BMEL encourages researchers to submit various types of papers, including original research articles, review articles, editorials, and letters to the editor, to promote academic discussion and knowledge sharing. These papers cover a wide range of topics from basic scientific research to clinical applications, aiming to provide a platform for professionals in the field of biomedical engineering to exchange the latest findings and viewpoints. The review process of BMEL uses a single-blind method, ensuring the fairness and transparency of the review while protecting the privacy of the authors. This rigorous peer-review mechanism ensures the quality of the published articles and plays an important role in promoting scientific development and technological innovation in the field of biomedical engineering.

《生物医学工程快报》（Biomedical Engineering Letters, BMEL）是一本专注于生物医学工程领域的学术期刊，它致力于快速传播该领域内的创新性实验科学、技术进步以及新兴的临床应用。该期刊强调发表具有原创性的生物医学工程研究，这包括新技术的创造、理论的深入分析以及技术的评估与验证工作。

BMEL 鼓励研究人员提交多种类型的论文，包括原创研究文章、综述文章、社论以及读者来信等，以促进学术讨论和知识共享。这些论文涵盖了从基础科学研究到临床应用的广泛主题，旨在为生物医学工程领域的专业人士提供一个交流最新发现和观点的平台。BMEL 的审稿流程采用单盲方式，确保了评审的公正性和透明度，同时保护了作者的隐私。这种严格的同行评审机制保证了发表的文章质量，对推动生物医学工程领域的科学发展和技术创新起到了重要作用。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映ENGINEERING, BIOMEDICAL领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.2，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。